For the first time, a functional beverage made with grape seed extract is shown to support healthy blood pressure within a normal range.
An estimated 30 percent of American adults have pre-hypertension, a condition that increases their risk of developing high blood pressure (i.e. hypertension) along with its potentially serious health consequences. Now there’s exciting new evidence that managing pre-hypertension may be as simple as enjoying a low-calorie beverage made with a patented grape seed extract, which is currently available only in supplement form.
This is the third human clinical study using MegaNatural-BP, a patented grape seed extract. The third study was conducted by researchers at the Center for Nutrition Research, Institute of Food Safety and Health at the Illinois Institute of Technology and was designed to test MegaNatural-BP as a functional ingredient in a beverage. Results will be presented by Dr. Britt Burton-Freeman and Dr. Eunyoung Park at Experimental Biology 2013. The conference will be held April 20-24 at the Boston Convention and Exhibition Center.
In the randomized, placebo-controlled study, 36 pre-hypertensive adults were randomized to drink either a beverage formulated with MegaNatural-BP or a placebo daily for six weeks. At the end of the study, those participants who consumed the drink containing the patented grape seed extract formula on average experienced significant reductions in systolic and diastolic blood pressure compared with those who consumed the placebo. For many, the reductions put them within a normal blood pressure range.
Polyphenolics, a division of Constellation Brands, Inc., manufactures, markets and sells ingredients for nutraceutical, functional and medical foods. To learn more about this research, attend the presentation during Experimental Biology 2013 or visit www.Polyphenolics.com.